Compile Data Set for Download or QSAR

Found 1 hit Enz. Inhib. hit(s) with Target = 'Mu-type opioid receptor' and Ligand = 'BDBM432137'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Mu-type opioid receptor (Homo sapiens (Human))	BDBM432137 (N-(1-Benzylpiperidin-4-yl)-N-[1-(4-fluorophenyl)-1...) Show SMILES Fc1ccc(cc1)-n1ccc(n1)N(C1CCN(Cc2ccccc2)CC1)C(=O)c1ccoc1 Show InChI InChI=1S/C26H25FN4O2/c27-22-6-8-23(9-7-22)30-16-12-25(28-30)31(26(32)21-13-17-33-19-21)24-10-14-29(15-11-24)18-20-4-2-1-3-5-20/h1-9,12-13,16-17,19,24H,10-11,14-15,18H2	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	<100	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
ESTEVE PHARMACEUTICALS, S.A. US Patent					Assay Description To investigate binding properties of test compounds to human μ-opioid receptor, transfected CHO-K1 cell membranes and [3H]-DAMGO (Perkin Elmer, ...				US Patent US10577360 (2020) BindingDB Entry DOI: 10.7270/Q2MC92DM
					More data for this Ligand-Target Pair